Mitelman, J., Giménez, L., Palacios, K., Tomasella, M., Acuna, L. and Avayú, D. (2011) New paradigms in Chagas Mazza disease.www.intramed.net/contenidover.aspncontenidoID=71783
has been cited by the following article:
TITLE: Cardiomyopathy protection in Chagas Disease
AUTHORS: Jorge E. Mitelman, Luisa Gimenez
KEYWORDS: Chagas Disease; Chronic Period without Demonstrable Pathology; Ex Indeterminate Phase; Endothelial Dysfunction; Cardiac Dysautonomia; Simvastatin; ACE (Angiotensin Converting Enzyme) Inhibitor; Muscarinic Antibody
JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.3 No.7, October 14, 2013
ABSTRACT: There is some published evidence suggesting micro vascular endothelial dysfunction and dysautonomia involvement in Chagas disease in association with cardiomyocyte changes favoring disease progression. The combined treatment between angiotensin converting enzyme (ACE) inhibitor drugs; Simvastatin, muscarinic antibody immunoadsorbent together with fungicidal drugs would open therapeutic possibilities in this disease.